BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31015766)

  • 1. Clinical features and prognostic factors of primary bone marrow lymphoma.
    Wang G; Chang Y; Wu X; Li X; Li L; Zhang L; Fu X; Sun Z; Zhang X; Zhang M
    Cancer Manag Res; 2019; 11():2553-2563. PubMed ID: 31015766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary bone marrow lymphoma: A hematological emergency in adults with fever of unknown origin.
    Wang HY; Yang CF; Chiou TJ; Gau JP; Chen PM; Tsai CY; Hsu HC; Wang FD; Liu JH; Hsiao LT
    Cancer Med; 2018 Aug; 7(8):3713-3721. PubMed ID: 29984910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggressive Diffuse Intermediate Size B-Cell Lymphoma With P53 Mutation Presented as Primary Bone Marrow Lymphoma.
    Chen PT; Jorsan K; Avezbakiyev B; Akhtar C; Wang JC
    J Investig Med High Impact Case Rep; 2020; 8():2324709620982765. PubMed ID: 33349058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary isolated bone marrow diffuse large B cell lymphoma with long-term complete remission.
    Nishida H; Suzuki H; Hori M; Obara K
    Leuk Res Rep; 2018; 10():11-15. PubMed ID: 30596009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison the efficacy and prognosis of different first-line treatment for elderly diffuse large B-cell lymphoma].
    Liu P; Jiang SY; He XH; Qin Y; Gui L; Zhou SY; Yang JL; Yang S; Wen TY; Shi YK
    Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):234-241. PubMed ID: 32252203
    [No Abstract]   [Full Text] [Related]  

  • 7. Primary bone marrow diffuse large B-cell lymphoma accompanying cold agglutinin disease: A case report with review of the literature.
    Yamashita T; Ishida M; Moro H; Yumoto H; Uchibayashi S; Yoshii M; Nakanishi R; Okuno H; Yoshida T; Okuno T; Hodohara K; Okabe H
    Oncol Lett; 2014 Jan; 7(1):79-81. PubMed ID: 24348825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow vascular endothelial growth factor level per platelet count might be a significant predictor for the treatment outcomes of patients with diffuse large B-cell lymphomas.
    Kim JS; Gang GW; Lee SR; Sung HJ; Park Y; Kim DS; Choi CW; Kim BS
    Jpn J Clin Oncol; 2015 Oct; 45(10):914-20. PubMed ID: 26185139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical Features, Treatment and Prognostic Factors of 94 Patients with Follicular Lymphoma].
    DU XY; Hu K; Zhao W; Yang P; Wan W; Jing HM; Ke XY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Jun; 26(3):756-764. PubMed ID: 29950216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic features and outcome in patients with diffuse large B-cell lymphoma who do not achieve a complete response to first-line regimens.
    Villela L; López-Guillermo A; Montoto S; Rives S; Bosch F; Perales M; Ferrer A; Esteve J; Colomo L; Campo E; Montserrat E
    Cancer; 2001 Apr; 91(8):1557-62. PubMed ID: 11301405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary bone marrow lymphoma: an uncommon extranodal presentation of aggressive non-hodgkin lymphomas.
    Martinez A; Ponzoni M; Agostinelli C; Hebeda KM; Matutes E; Peccatori J; Campidelli C; Espinet B; Perea G; Acevedo A; Mehrjardi AZ; Martinez-Bernal M; Gelemur M; Zucca E; Pileri S; Campo E; López-Guillermo A; Rozman M;
    Am J Surg Pathol; 2012 Feb; 36(2):296-304. PubMed ID: 22251943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A retrospective analysis of clinical characteristics and prognostic factors for 124 cases of primary gastric lymphomas].
    He Y; Wang L; Zhu HY; Liang JH; Wu W; Wu JZ; Xia Y; Cao L; Fan L; Li JY; Xu W
    Zhonghua Xue Ye Xue Za Zhi; 2017 Jun; 38(6):505-510. PubMed ID: 28655094
    [No Abstract]   [Full Text] [Related]  

  • 13. [Tumors of lymphoid and hematopoietic tissue of spleen: a clinicopathologic analysis of 53 cases].
    Chen DB; Shen DH; Zhang H; Wang Y; Song QJ; Yang SM; Fang XZ
    Zhonghua Bing Li Xue Za Zhi; 2017 Nov; 46(11):775-781. PubMed ID: 29136691
    [No Abstract]   [Full Text] [Related]  

  • 14. Follicular large-cell lymphoma treated with intensive chemotherapy: an analysis of 89 cases included in the LNH87 trial and comparison with the outcome of diffuse large B-cell lymphoma. Groupe d'Etude des Lymphomes de l'Adulte.
    Wendum D; Sebban C; Gaulard P; Coiffier B; Tilly H; Cazals D; Boehn A; Casasnovas RO; Bouabdallah R; Jaubert J; Ferrant A; Diebold J; de Mascarel A; Gisselbrecht C
    J Clin Oncol; 1997 Apr; 15(4):1654-63. PubMed ID: 9193366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of prognostic risk factors in patients with diffuse large B-cell lymphoma].
    Yu ZP; Ding JH; Chen BA; Gao C; Wang LL; Chen Z
    Zhonghua Xue Ye Xue Za Zhi; 2011 Dec; 32(12):830-5. PubMed ID: 22339956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical features and prognosis of children with mature B-cell non-Hodgkin's lymphoma: an analysis of 28 cases].
    Chen ZS; Zheng YZ; Chen YQ; Gao QL; Li J; Shen JZ
    Zhongguo Dang Dai Er Ke Za Zhi; 2018 Jun; 20(6):470-474. PubMed ID: 29972121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
    Plosker GL; Figgitt DP
    Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and Prognostic analysis of 43 Children with Mature B-cell Non-Hodgkin's Lymphoma/Acute Lymphoblastic Leukemia].
    Guo J; Zhu YP; Gao J; Li Q; Jia CS; Zhou CY; Guo X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):72-9. PubMed ID: 26913397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffuse large cell lymphomas: identification of prognostic factors and validation of the International Non-Hodgkin's Lymphoma Prognostic Index. A Hellenic Cooperative Oncology Group Study.
    Nicolaides C; Fountzilas G; Zoumbos N; Skarlos D; Kosmidis P; Pectasides D; Karabelis A; Giannakakis T; Symeonidis A; Papadopoulos A; Antoniou F; Pavlidis N
    Oncology; 1998; 55(5):405-15. PubMed ID: 9732217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive model for prognosis in advanced diffuse histiocytic lymphoma.
    Danieu L; Wong G; Koziner B; Clarkson B
    Cancer Res; 1986 Oct; 46(10):5372-9. PubMed ID: 3530438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.